ADMA compared with HRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

ADMAAdma Biologics, Inc.

Mkt capRevenueRevenue

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ADMAAdma Biologics, Inc.

HRTXHeron Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ADMA, solidHRTX, dashed

Supply-chain overlap

Revenue flow

HRTX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ADMA 7

GRFSGrifols Worldwide Operationssupplier

—KEDPlasmaunlistedsupplier

—Areth, LLC ("Areth")unlistedsupplier

—Priority Healthcare Distributionunlistedcustomer

3 more · ADMA chain ›

Shared 0

No disclosed counterparties: HRTX.

Only HRTX 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ADMAAdma Biologics, Inc.

11.41▼−2.90%· post 11.41

Mkt cap$2.6BRevenue$124MQ2 FY26Revenue$510MFY25

HRTXHeron Therapeutics, Inc.

0.28▼−4.38%· post 0.28

ClosedOct 30 '26

Mkt cap$52.7MRevenue$38MQ2 FY26Revenue$155MFY25

Compare

ClosedOct 30 '26

ADMAAdma Biologics, Inc.

HRTXHeron Therapeutics, Inc.

11.41▼−2.90%post 11.41

Price

0.28▼−4.38%post 0.28

$2.6B

Mkt cap

$52.7M

Q2 FY26$124M

Revenue

$38MQ2 FY26

FY25$510M

Revenue

$155MFY25

ADMA11.41▼−2.90%vsHRTX0.28▼−4.38%ClosedOct 30 '26